Hari Anant Deshpande, MD

Associate Professor of Medicine (Medical Oncology)

Clinical Interests

  • Medical Oncology
  • Sarcoma

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Endocrine Oncology Program | Head and Neck Cancers Program | Prostate and Urologic Cancers Program

General Urology

Medical Oncology: Subset Medical Oncology Faculty

Medical Oncology

Yale Medical Group

Board Certifications

  • Hematology (Internal Medicine) AB of Internal Medicine (1998)

  • Medical Oncology AB of Internal Medicine (1999)

Clinical Trials

Conditions Study Title
Prostate EC1169-01:Phase I study of PSA Targeting Tubulysin Conjugate EC1169 in Patients with recurrent mCRPC
Larynx, Lip, Oral Cavity and Pharynx, Thyroid Study of Pembrolizumab (MK-3475) for 1st Line Tx of Recurrent/Metastatic Squamous Cell Ca of H&N
Prostate ARMOR3-SV: Phase 3 trial of Galeterone Compared to Enzalutamide AR-V7 M1 CRPC
Bladder, Other Urinary JVDC 05 (RANGE): Ramucirumab Plus Docetaxel in Participants With Urothelial Cancer
Bladder, Other Urinary ML29725: Expanded access program for atezolizumab in metastatic urothelial cancer
Bladder, Lung, Other Digestive Organ, Other Urinary, Stomach Ramucirumab + Pembro with Gastric or GEJ Adenocarcinoma, NSCLC or Tcell carcinoma of urothelium
Larynx, Lip, Oral Cavity and Pharynx A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 With Tremelimumab or T
Lip, Oral Cavity and Pharynx NRG-HN002: Testing less intensive treatment for selected low-risk patients with oropharyngeal cancer
Other Endocrine System A091202: Efatutazone vs. Placebo in Pts With Previously Treated, Unresectable Myxoid Liposarcoma
Soft Tissue Individualized treatment for nasopharyngeal cancer based on the patient's DNA
Bladder S1011: Standard or Extended Pelvic Lymphadenectomy in Pts to have Surgery for Invasive Bladder Canc
Brain and Nervous System Germ Cell Tumor Pediatric CIRB study
Soft Tissue ARST1321 Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Bones and Joints AEWS1221 Newly Diagnosed Metastatic Ewing Sarcoma
Bladder Novartis BGJ398: A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Stomach MK-3475 versus Standard Treatment in Subjects with Recurrent or Metastatic Head and Neck Cancer
Kidney S0931: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Soft Tissue RTOG 3501 (TRYHARD)
Prostate Medivation (PROSPER): Phase 3 Randomized, Double-Blind Study of Enzalutamide for Nonmetastatic CRPC
Lip, Oral Cavity and Pharynx E3311: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy w/ or w/out Chemo

Edit this profile

Contact Info

Hari Anant Deshpande, MD
Patient Care Locations
Yale Cancer CenterSmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 4th Floor

New Haven, CT 06511
View on map...
Smilow Cancer CareYale-New Haven Hospital Saint Raphael Campus
1450 Chapel Street, Ste Suite A

New Haven, CT 06511
View on map...
Mailing Address
PO Box 208028
333 Cedar Street,

New Haven, CT 06520-8028